| QYA | Name: | 2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(4-sulfamoylphenyl)acetamide | Formula: | C12 H12 N4 O5 S | SMILES: | C1=CC(NC(N1CC(Nc2ccc(cc2)S(N)(=O)=O)=O)=O)=O | InChi: | InChI=1S/C12H12N4O5S/c13-22(20,21)9-3-1-8(2-4-9)14-11(18)7-16-6-5-10(17)15-12(16)19/h1-6H,7H2,(H,14,18)(H2,13,20,21)(H,15,17,19) | Definition date: | 2020-01-15 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(4-sulfamoylphenyl)acetamide |
|
| CQC | Name: | 5-[(~{Z})-(1,3-dimethyl-5-oxidanylidene-pyrazol-4-ylidene)-oxidanyl-methyl]-2-(phenylmethyl)isoindole-1,3-dione | Formula: | C21 H17 N3 O4 | SMILES: | CN1N=C(C)C(=C(O)c2ccc3C(=O)N(Cc4ccccc4)C(=O)c3c2)C1=O | InChi: | InChI=1S/C21H17N3O4/c1-12-17(21(28)23(2)22-12)18(25)14-8-9-15-16(10-14)20(27)24(19(15)26)11-13-6-4-3-5-7-13/h3-10,25H,11H2,1-2H3/b18-17- | Definition date: | 2019-05-10 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 5-[(~{Z})-(1,3-dimethyl-5-oxidanylidene-pyrazol-4-ylidene)-oxidanyl-methyl]-2-(phenylmethyl)isoindole-1,3-dione |
|
| RYA | Name: | (7~{R})-2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7-dimethyl-8-prop-2-ynyl-7~{H}-pteridin-6-one | Formula: | C17 H15 F2 N5 O2 | SMILES: | C[CH]1N(CC#C)c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C1=O | InChi: | InChI=1S/C17H15F2N5O2/c1-4-5-24-9(2)16(26)23(3)13-8-20-17(22-15(13)24)21-10-6-11(18)14(25)12(19)7-10/h1,6-9,25H,5H2,2-3H3,(H,20,21,22)/t9-/m1/s1 | Definition date: | 2020-03-02 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | (7~{R})-2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7-dimethyl-8-prop-2-ynyl-7~{H}-pteridin-6-one |
|
| RZG | Name: | methyl 4-sulfamoylbenzoate | Formula: | C8 H9 N O4 S | SMILES: | COC(=O)c1ccc(cc1)[S](N)(=O)=O | InChi: | InChI=1S/C8H9NO4S/c1-13-8(10)6-2-4-7(5-3-6)14(9,11)12/h2-5H,1H3,(H2,9,11,12) | Definition date: | 2020-03-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | methyl 4-sulfamoylbenzoate |
|
| RZJ | Name: | 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide | Formula: | C10 H14 N2 O2 S | SMILES: | CN1CCCc2ccc(cc12)[S](N)(=O)=O | InChi: | InChI=1S/C10H14N2O2S/c1-12-6-2-3-8-4-5-9(7-10(8)12)15(11,13)14/h4-5,7H,2-3,6H2,1H3,(H2,11,13,14) | Definition date: | 2020-03-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide |
|
| EQ9 | Name: | 1-(2-azanylpyridin-4-yl)-3-[5-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]pentyl]imidazolidin-2-one | Formula: | C22 H26 N6 O3 | SMILES: | Cc1onc(n1)c2ccc(OCCCCCN3CCN(C3=O)c4ccnc(N)c4)cc2 | InChi: | InChI=1S/C22H26N6O3/c1-16-25-21(26-31-16)17-5-7-19(8-6-17)30-14-4-2-3-11-27-12-13-28(22(27)29)18-9-10-24-20(23)15-18/h5-10,15H,2-4,11-14H2,1H3,(H2,23,24) | Definition date: | 2020-01-20 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 1-(2-azanylpyridin-4-yl)-3-[5-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]pentyl]imidazolidin-2-one |
|
| H6W | Name: | ~{N}-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-~{N}',~{N}'-dimethyl-propane-1,3-diamine | Formula: | C18 H21 N5 O2 | SMILES: | CN(C)CCCNc1ccn2ncc(c3ccc4OCOc4c3)c2n1 | InChi: | InChI=1S/C18H21N5O2/c1-22(2)8-3-7-19-17-6-9-23-18(21-17)14(11-20-23)13-4-5-15-16(10-13)25-12-24-15/h4-6,9-11H,3,7-8,12H2,1-2H3,(H,19,21) | Definition date: | 2018-11-19 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | ~{N}-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-~{N}',~{N}'-dimethyl-propane-1,3-diamine |
|
| H72 | Name: | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide | Formula: | C19 H16 N6 O | SMILES: | NC(=O)c1ccc(cc1)c2cnn3ccc(NCc4cccnc4)nc23 | InChi: | InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24) | Definition date: | 2018-11-19 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
|
| HWH | Name: | ~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide | Formula: | C12 H13 F N2 O | SMILES: | CC(=O)NCCc1c[nH]c2ccc(F)cc12 | InChi: | InChI=1S/C12H13FN2O/c1-8(16)14-5-4-9-7-15-12-3-2-10(13)6-11(9)12/h2-3,6-7,15H,4-5H2,1H3,(H,14,16) | Definition date: | 2019-01-01 | Last modified: | 2020-03-03 | Release date: | 2020-01-08 | Identifier: | ~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide |
|
| YZM | Name: | N-carbamoylbenzamide | Formula: | C8 H8 N2 O2 | SMILES: | O=C(NC(=O)N)c1ccccc1 | InChi: | InChI=1S/C8H8N2O2/c9-8(12)10-7(11)6-4-2-1-3-5-6/h1-5H,(H3,9,10,11,12) | Definition date: | 2012-12-18 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | N-carbamoylbenzamide |
|
| J95 | Name: | ~{N}-butyl-4-chloranyl-2-(cyclohexylamino)-5-sulfamoyl-benzamide | Formula: | C17 H26 Cl N3 O3 S | SMILES: | CCCCNC(=O)c1cc(c(Cl)cc1NC2CCCCC2)[S](N)(=O)=O | InChi: | InChI=1S/C17H26ClN3O3S/c1-2-3-9-20-17(22)13-10-16(25(19,23)24)14(18)11-15(13)21-12-7-5-4-6-8-12/h10-12,21H,2-9H2,1H3,(H,20,22)(H2,19,23,24) | Definition date: | 2019-02-12 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | ~{N}-butyl-4-chloranyl-2-(cyclohexylamino)-5-sulfamoyl-benzamide |
|
| J9Q | Name: | 2-(1,3-oxazol-5-yl)aniline | Formula: | C9 H8 N2 O | SMILES: | Nc1ccccc1c2ocnc2 | InChi: | InChI=1S/C9H8N2O/c10-8-4-2-1-3-7(8)9-5-11-6-12-9/h1-6H,10H2 | Definition date: | 2019-02-12 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 2-(1,3-oxazol-5-yl)aniline |
|
| JAW | Name: | 1~{H}-indole-5-carboxamide | Formula: | C9 H8 N2 O | SMILES: | NC(=O)c1ccc2[nH]ccc2c1 | InChi: | InChI=1S/C9H8N2O/c10-9(12)7-1-2-8-6(5-7)3-4-11-8/h1-5,11H,(H2,10,12) | Definition date: | 2019-02-13 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 1~{H}-indole-5-carboxamide |
|
| KJE | Name: | 18-carboxymethoxy-cleaviminium | Formula: | C21 H25 N2 O2 | SMILES: | CCC1=C[CH]2C[CH](C(=O)OC)C3=Nc4ccccc4[CH]3CC[N+](=C1)C2 | InChi: | InChI=1S/C21H25N2O2/c1-3-14-10-15-11-18(21(24)25-2)20-17(8-9-23(12-14)13-15)16-6-4-5-7-19(16)22-20/h4-7,10,12,15,17-18H,3,8-9,11,13H2,1-2H3/q+1/t15-,17+,18+/m0/s1 | Definition date: | 2019-05-22 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 |
|
| JBB | Name: | 3-(thiophen-2-ylsulfanylmethyl)benzoic acid | Formula: | C12 H10 O2 S2 | SMILES: | OC(=O)c1cccc(CSc2sccc2)c1 | InChi: | InChI=1S/C12H10O2S2/c13-12(14)10-4-1-3-9(7-10)8-16-11-5-2-6-15-11/h1-7H,8H2,(H,13,14) | Definition date: | 2019-02-13 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 3-(thiophen-2-ylsulfanylmethyl)benzoic acid |
|
| JBN | Name: | 1,2-oxazole-5-carboxamide | Formula: | C4 H4 N2 O2 | SMILES: | NC(=O)c1oncc1 | InChi: | InChI=1S/C4H4N2O2/c5-4(7)3-1-2-6-8-3/h1-2H,(H2,5,7) | Definition date: | 2019-02-13 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 1,2-oxazole-5-carboxamide |
|
| KXW | Name: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(pyridin-2-ylamino)propyl]amino]-2-azanyl-butanoic acid | Formula: | C22 H31 N9 O5 | SMILES: | N[CH](CCN(CCCNc1ccccn1)C[CH]2O[CH]([CH](O)[CH]2O)n3cnc4c(N)ncnc34)C(O)=O | InChi: | InChI=1S/C22H31N9O5/c23-13(22(34)35)5-9-30(8-3-7-26-15-4-1-2-6-25-15)10-14-17(32)18(33)21(36-14)31-12-29-16-19(24)27-11-28-20(16)31/h1-2,4,6,11-14,17-18,21,32-33H,3,5,7-10,23H2,(H,25,26)(H,34,35)(H2,24,27,28)/t13-,14+,17+,18+,21+/m0/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(pyridin-2-ylamino)propyl]amino]-2-azanyl-butanoic acid |
|
| KY2 | Name: | 1-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]propyl]guanidine | Formula: | C17 H30 N10 O3 | SMILES: | NCCCN(CCCNC(N)=N)C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C17H30N10O3/c18-3-1-5-26(6-2-4-22-17(20)21)7-10-12(28)13(29)16(30-10)27-9-25-11-14(19)23-8-24-15(11)27/h8-10,12-13,16,28-29H,1-7,18H2,(H2,19,23,24)(H4,20,21,22)/t10-,12-,13-,16-/m1/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 1-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]propyl]guanidine |
|
| KY5 | Name: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyridin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol | Formula: | C21 H31 N9 O3 | SMILES: | NCCCN(CCCNc1ccccn1)C[CH]2O[CH]([CH](O)[CH]2O)n3cnc4c(N)ncnc34 | InChi: | InChI=1S/C21H31N9O3/c22-6-3-9-29(10-4-8-25-15-5-1-2-7-24-15)11-14-17(31)18(32)21(33-14)30-13-28-16-19(23)26-12-27-20(16)30/h1-2,5,7,12-14,17-18,21,31-32H,3-4,6,8-11,22H2,(H,24,25)(H2,23,26,27)/t14-,17-,18-,21-/m1/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyridin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol |
|
| KY8 | Name: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyrimidin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol | Formula: | C20 H30 N10 O3 | SMILES: | NCCCN(CCCNc1ncccn1)C[CH]2O[CH]([CH](O)[CH]2O)n3cnc4c(N)ncnc34 | InChi: | InChI=1S/C20H30N10O3/c21-4-1-8-29(9-3-7-25-20-23-5-2-6-24-20)10-13-15(31)16(32)19(33-13)30-12-28-14-17(22)26-11-27-18(14)30/h2,5-6,11-13,15-16,19,31-32H,1,3-4,7-10,21H2,(H2,22,26,27)(H,23,24,25)/t13-,15-,16-,19-/m1/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyrimidin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol |
|
| KYB | Name: | 1-[5-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]pentyl]guanidine | Formula: | C19 H34 N10 O3 | SMILES: | NCCCN(CCCCCNC(N)=N)C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C19H34N10O3/c20-5-4-8-28(7-3-1-2-6-24-19(22)23)9-12-14(30)15(31)18(32-12)29-11-27-13-16(21)25-10-26-17(13)29/h10-12,14-15,18,30-31H,1-9,20H2,(H2,21,25,26)(H4,22,23,24)/t12-,14-,15-,18-/m1/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 1-[5-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]pentyl]guanidine |
|
| KYE | Name: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(5-carbamimidamidopentyl)amino]-2-azanyl-butanoic acid | Formula: | C20 H34 N10 O5 | SMILES: | N[CH](CCN(CCCCCNC(N)=N)C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23)C(O)=O | InChi: | InChI=1S/C20H34N10O5/c21-11(19(33)34)4-7-29(6-3-1-2-5-25-20(23)24)8-12-14(31)15(32)18(35-12)30-10-28-13-16(22)26-9-27-17(13)30/h9-12,14-15,18,31-32H,1-8,21H2,(H,33,34)(H2,22,26,27)(H4,23,24,25)/t11-,12+,14+,15+,18+/m0/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(5-carbamimidamidopentyl)amino]-2-azanyl-butanoic acid |
|
| KYH | Name: | 1-[4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]butyl]guanidine | Formula: | C18 H32 N10 O3 | SMILES: | NCCCN(CCCCNC(N)=N)C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C18H32N10O3/c19-4-3-7-27(6-2-1-5-23-18(21)22)8-11-13(29)14(30)17(31-11)28-10-26-12-15(20)24-9-25-16(12)28/h9-11,13-14,17,29-30H,1-8,19H2,(H2,20,24,25)(H4,21,22,23)/t11-,13-,14-,17-/m1/s1 | Definition date: | 2019-07-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 1-[4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]butyl]guanidine |
|
| LKY | Name: | 3-cyano-N-(3-{[(3S)-4-(cyclopentanecarbonyl)-3-methylpiperazin-1-yl]methyl}-5-fluoro-2-methylphenyl)benzamide | Formula: | C27 H31 F N4 O2 | SMILES: | c1(c(cc(cc1CN2CC(C)N(CC2)C(C3CCCC3)=O)F)NC(=O)c4cc(ccc4)C#N)C | InChi: | InChI=1S/C27H31FN4O2/c1-18-16-31(10-11-32(18)27(34)21-7-3-4-8-21)17-23-13-24(28)14-25(19(23)2)30-26(33)22-9-5-6-20(12-22)15-29/h5-6,9,12-14,18,21H,3-4,7-8,10-11,16-17H2,1-2H3,(H,30,33)/t18-/m0/s1 | Definition date: | 2019-02-28 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | 3-cyano-N-(3-{[(3S)-4-(cyclopentanecarbonyl)-3-methylpiperazin-1-yl]methyl}-5-fluoro-2-methylphenyl)benzamide |
|
| LMV | Name: | (2~{S})-4-(cyclobutylmethyl)-2-(2,4-dichlorophenyl)-~{N}-(2-methylpropylsulfonyl)-2,3-dihydro-1,4-benzoxazine-6-carboxamide | Formula: | C24 H28 Cl2 N2 O4 S | SMILES: | CC(C)C[S](=O)(=O)NC(=O)c1ccc2O[CH](CN(CC3CCC3)c2c1)c4ccc(Cl)cc4Cl | InChi: | InChI=1S/C24H28Cl2N2O4S/c1-15(2)14-33(30,31)27-24(29)17-6-9-22-21(10-17)28(12-16-4-3-5-16)13-23(32-22)19-8-7-18(25)11-20(19)26/h6-11,15-16,23H,3-5,12-14H2,1-2H3,(H,27,29)/t23-/m1/s1 | Definition date: | 2019-03-04 | Last modified: | 2020-02-28 | Release date: | 2020-03-04 | Identifier: | (2~{S})-4-(cyclobutylmethyl)-2-(2,4-dichlorophenyl)-~{N}-(2-methylpropylsulfonyl)-2,3-dihydro-1,4-benzoxazine-6-carboxamide |
|